相关实验视频

Updated: Jul 16, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

关于在艾滋病毒耐药性研究中的数据共享的建议

Seth C Inzaule¹, Mark J Siedner², Susan J Little³

¹Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

|September 22, 2023

概括

分享人类免疫缺陷病毒 (HIV) 耐药性数据对于治疗和流行病控制至关重要. 建议促进标准化,安全的数据共享,以推进艾滋病毒研究和指导方针.

科学领域:

* 病毒学和传染病学
* 公共卫生和流行病学
* 生物信息学和基因组学

背景情况:

*艾滋病毒耐药性使治疗复杂化,需要更有效,更耐受,更实惠的抗逆转录病毒药物.
*了解药物选择的HIV突变是管理治疗和流行病的关键.
*现有的HIV耐药性研究产生了宝贵的数据,但通常不会公开分享.

研究的目的:

*概述鼓励和标准化共享艾滋病毒耐药性数据的最佳实践.
* 应对因许多地区将传播罪行化而导致的共享艾滋病毒序列数据的挑战.
* 确保艾滋病毒耐药性数据的可用性,而不损害患者的隐私或造成不必要的负担.

主要方法:

* 审查现有的HIV耐药性研究和数据共享实践.
*分析与分享敏感的HIV遗传数据相关的挑战和风险.
* 制定标准化和安全的数据共享协议的建议.

主要成果:

* 存在着对标准化,公开可访问的HIV耐药性数据的迫切需要.
*共享艾滋病毒序列数据需要仔细考虑法律和伦理方面的影响,特别是关于传播的刑事犯罪.
* 建议建议旨在促进数据共享,同时降低艾滋病毒感染者的风险.

结论:

*对艾滋病毒耐药性数据的标准化共享对于有效的艾滋病毒治疗和全球流行病控制至关重要.
* 实施推的最佳实践将增强艾滋病毒研究和公共卫生的集体知识基础.
*安全和道德的数据共享协议对于促进我们对艾滋病毒耐药性的理解和管理至关重要.

更多相关视频

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...